Combo Therapy Shows Mixed Results for SSc-Related Lung Disease
A study of mycophenolate mofetil alone and in combination with pirfenidone for scleroderma-related interstitial lung disease showed mixed results.
Source: medscape.com
Stay updated with breaking news from Scleroderma Lung Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A study of mycophenolate mofetil alone and in combination with pirfenidone for scleroderma-related interstitial lung disease showed mixed results.
Being underweight and losing 2 kg or more over the course of 1 year were both associated with higher mortality risk in patients with fibrotic interstitial lung disease.